Anti-p27 KIP1 Monoclonal Antibody

品牌：solarbio | 货号：K001454M

商品货号：	商品品牌：	规格	基本售价：	选择规格
K001454M-50ul	solarbio	50ul	960.00元
K001454M-100ul	solarbio	100ul	1600.00元

英文名称 Anti-p27 KIP1 Monoclonal Antibody
别名 CDKN4;KIP1;MEN1B;MEN4;P27KIP1
应用 WB
稀释比例 WB 1:1000.
交叉反应 Mouse
蛋白分子量 27kDa
Gene ID 1027
保存 Store at -20°C. Avoid freeze / thaw cycles.
储存液 Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
纯化方法 Affinity purification
亚型 IgG1
免疫原 Purified recombinant human p27 Kip1 protein fragments expressed in E.coli.
性状 液体
Public Immunogen Range Purified recombinant human p27 Kip1 protein fragments expressed in E.coli.
Subcellular Locations Cytoplasm Endosome Nucleus
Swiss Prot P46527
克隆号 5B4-E6-E11-A8
克隆类型 Monoclonal Antibody
背景资料 This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4).

英文名称	Anti-p27 KIP1 Monoclonal Antibody
别名	CDKN4;KIP1;MEN1B;MEN4;P27KIP1
应用	WB
稀释比例	WB 1:1000.
交叉反应	Mouse
蛋白分子量	27kDa
Gene ID	1027
保存	Store at -20°C. Avoid freeze / thaw cycles.
储存液	Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
纯化方法	Affinity purification
亚型	IgG1
免疫原	Purified recombinant human p27 Kip1 protein fragments expressed in E.coli.
性状	液体
Public Immunogen Range	Purified recombinant human p27 Kip1 protein fragments expressed in E.coli.
Subcellular Locations	Cytoplasm Endosome Nucleus
Swiss Prot	P46527
克隆号	5B4-E6-E11-A8
克隆类型	Monoclonal Antibody
背景资料	This gene encodes a cyclin-dependent kinase inhibitor, which shares a limited similarity with CDK inhibitor CDKN1A/p21. The encoded protein binds to and prevents the activation of cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus controls the cell cycle progression at G1. The degradation of this protein, which is triggered by its CDK dependent phosphorylation and subsequent ubiquitination by SCF complexes, is required for the cellular transition from quiescence to the proliferative state. Mutations in this gene are associated with multiple endocrine neoplasia type IV (MEN4).